Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System
Our results suggest that incretin-related drugs, especially GLP-1RAs, reduce the risk of fractures in patients treated with diabetes medications such as pioglitazone.
PDF的下载单位、IP信息已删除
(2025-6-4)
invisight
Yinxb
DW
蓝天
xing_xing
aajhajkahna
aaaa
科研狗
林狗
pluto
璐璐
123
秦艽
嘻嘻哈哈
小迪
猖狂战神
七听
学术文献互助
123
极限001
皖公网安备34019202002308
